| 产品详情 |
| Edit |   |
|---|
| Product Name | Bevacizumab (Avastin®) BioAssay™ ELISA Kit |
|---|
| Description | Bevacizumab (Avastin®) is a recombinant humanized monoclonal antibody that blocks angiogenesis by inhibiting vascular endothelial growth factor A (VEGFA). VEGF-A stimulates angiogenesis in a variety of diseases, including cancer. Bevacizumab was the first clinically available angiogenesis inhibitor in the United States. Sample Type: Serum and plasma Intended Use: The Bevacizumab PK BioAssay™ ELISA kit is designed to measure Bevacizumab in serum or plasma with high specificity and sensitivity. This sandwich ELISA design employs a Bevacizumab specific monoclonal antibody for capture and a specific monoclonal antibody for detection. Sensitivity: <2ng/ml Specificity: hIgG1, rituximab, and infliximab prepared at 250ng/mL were assayed and exhibited no crossreactivity or interference. Recovery: 250ng/mL of Bevacizumab was spiked in 10 lots of human serum. Recovery ranges are from 91-117% with an average recovery of 106%. Precision: Intra-assay CV: <10% Inter-assay CV: <10%. Test Principle: Th |
|---|
| Size | 96 tests |
|---|
| Concentration | n/a |
|---|
| Applications | ELISA |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 384859 |
|---|
| Price | |
|---|
| Order / More Info | Bevacizumab (Avastin®) BioAssay™ ELISA Kit from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|